More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]
Swiss Franc LIBOR
Antitrust, Commodities
Lowey Dannenberg is the court-appointed sole lead counsel in a class action against numerous global financial institutions responsible for setting the London Interbank Offered Rate for the Swiss Franc (Swiss […]
Euribor
Antitrust, Commodities
Lowey Dannenberg is leading the prosecution against the global financial institutions responsible for the setting of the Euro Interbank Offered Rate (“Euribor”), a global reference rate used to benchmark, price […]
News
Lowey Secures $105 Million Recovery for BBSW Investors
On December 10, 2021, Plaintiffs in Dennis, et al. v. JPMorgan Chase & Co., et al., No. 16-cv-06496 (S.D.N.Y.) announced that they entered settlement agreements with Morgan Stanley, Morgan Stanley Australia Limited, Australia and New Zealand Banking Group…
Blog
Rule 10b5-1 Trading Plans Under Scrutiny: Are They Subject To Insider Trading Abuse?
The U.S. Securities and Exchange Commission (SEC) is working to overhaul the rule that protects corporate executives from insider trading accusations when they buy or sell their company’s stocks. Executives are regularly exposed to material nonpublic information (MNPI) and would be at risk of…